Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.

“The Ovum Wand launch reinforces Mira’s goal to support women throughout their lives by helping them understand their hormones at any age, be it puberty, adulthood, or later years.” Sylvia Kang, Mira Co-founder & CEO 


Male contraception company YourChoice Therapeutics adds $15M in Series A funding to kick off human trials.

You’ve found some of our exclusive Inner Circle Content.

This article is only available for our Inner Circle Members. To read on: